<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with subgroups that differ in prognosis, including risk of transformation to <z:hpo ids='HP_0001909'>leukemia</z:hpo> and also in survival rate </plain></SENT>
<SENT sid="1" pm="."><plain>An analysis was conducted of <z:hpo ids='HP_0011420'>deaths</z:hpo> in US residents with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> coded on the <z:hpo ids='HP_0011420'>death</z:hpo> certificate, for surveillance of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-related <z:hpo ids='HP_0011420'>death</z:hpo> rates </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> was coded for 18,304 <z:hpo ids='HP_0011420'>deaths</z:hpo> in 2005-2006 (age-standardized rate = 2.98 per 100,000 per year) using multiple causes of <z:hpo ids='HP_0011420'>death</z:hpo> vs 9,995 (age-standardized rate =1.63 per 100,000 per year) using only the underlying cause of <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>For <z:hpo ids='HP_0011420'>deaths</z:hpo> with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> mentioned as other than the underlying cause, the most common underlying causes were <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (of which 65% were <z:hpo ids='HP_0001909'>leukemia</z:hpo>) and <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Thus, surveillance of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-related mortality is unusual in comparison to most types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, in that use of multiple causes of <z:hpo ids='HP_0011420'>death</z:hpo> is required, as also previously reported for myeloproliferative <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Use of multiple causes improves estimation of the burden of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-related <z:hpo ids='HP_0011420'>deaths</z:hpo> in the population, which enhances the importance of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> in planning <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> research and control efforts </plain></SENT>
<SENT sid="6" pm="."><plain>Linkages with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registries should be conducted to evaluate the accuracy of data on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> as a cause of <z:hpo ids='HP_0011420'>death</z:hpo> on <z:hpo ids='HP_0011420'>death</z:hpo> records, for use in interpreting surveillance data on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-related mortality </plain></SENT>
</text></document>